Commonly prescribed blood thinners linked to slower cognitive decline in Alzheimer's patients
Photo: Towfiqu barbhuiya / Unsplash
A new study reveals that newer blood thinners, known as NOACs, may offer a dual benefit for people living with both Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking these medications experienced a slower rate of cognitive decline compared to those on older treatments or no blood thinners at all, suggesting a promising way to help preserve brain health over time.
A new study reveals that newer blood thinners, known as NOACs, may offer a dual benefit for people living with both Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking these medications experienced a slower rate of cognitive decline compared to those on older treatments or no blood thinners at all, suggesting a promising way to help preserve brain health over time.